DISCRIMINATIVE STIMULUS PROPERTIES OF FLESINOXAN

被引：1
|
作者：
YBEMA, CE
SLANGEN, JL
OLIVIER, B
MOS, J
机构：
[1] FAC PHARM UTRECHT,3584 CA UTRECHT,NETHERLANDS
[2] DUPHAR BV,1380 AA WEESP,NETHERLANDS
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1990年 / 183卷 / 05期
关键词：
D O I：
10.1016/0014-2999(90)92266-L
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1921 / 1922
页数：2
相关论文
共 50 条
  • [1] DISCRIMINATIVE STIMULUS PROPERTIES OF FLESINOXAN
    YBEMA, CE
    SLANGEN, JL
    OLIVIER, B
    MOS, J
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 35 (04) : 781 - 784
  • [2] DISCRIMINATIVE STIMULUS PROPERTIES OF FLESINOXAN - EFFECTS OF ENANTIOMERS, (S)-UH301 AND WAY-100635
    GOMMANS, J
    HIJZEN, TH
    MAES, RA
    MOS, J
    OLIVIER, B
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 284 (1-2) : 135 - 140
  • [3] DISCRIMINATIVE STIMULUS EFFECT OF FLESINOXAN - EFFECTS OF 5-HT1A ANTAGONISTS AND PCPA
    YBEMA, CE
    SLANGEN, JL
    OLIVIER, B
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 47 (04) : 957 - 962
  • [4] DISCRIMINATIVE STIMULUS PROPERTIES OF DESIPRAMINE
    SHEARMAN, G
    MIKSIC, S
    LAL, H
    NEUROPHARMACOLOGY, 1978, 17 (12) : 1045 - 1048
  • [5] Discriminative stimulus properties of antipsychotics
    Goudie, AJ
    Smith, JA
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1999, 64 (02) : 193 - 201
  • [6] Discriminative stimulus properties of (-)ephedrine
    Young, R
    Glennon, RA
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 60 (03) : 771 - 775
  • [7] Discriminative stimulus properties of tianeptine
    Tevfik Alici
    Hakan Kayir
    M. Oguz Aygoren
    Esra Saglam
    I. Tayfun Uzbay
    Psychopharmacology, 2006, 183 : 446 - 451
  • [8] DISCRIMINATIVE STIMULUS PROPERTIES OF PHENCYCLIDINE
    BROWNE, RG
    PSYCHOPHARMACOLOGY, 1982, 76 (04) : A5 - A5
  • [9] DISCRIMINATIVE STIMULUS PROPERTIES OF ANTIDEPRESSANTS
    HOWARD, JL
    JONES, CN
    MCBENNETT, ST
    PSYCHOPHARMACOLOGY, 1978, 58 (02) : 6 - 6
  • [10] Discriminative stimulus properties of alprazolam
    Gommans, J
    Hijzen, TH
    Maes, RAA
    Olivier, B
    PSYCHOPHARMACOLOGY, 2000, 148 (02) : 146 - 152
12345